SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-001433
Filing Date
2024-02-12
Accepted
2024-02-12 16:33:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 CALIDI BIOTHERAPEUTICS, INC. p24-0707sc13ga.htm SC 13G/A 44583
  Complete submission text file 0000902664-24-001433.txt   46402
Mailing Address 4 EMBARCADERO CENTER SUITE 3450 SAN FRANCISCO CA 94111
Business Address 4 EMBARCADERO CENTER SUITE 3450 SAN FRANCISCO CA 94111 415-801-4550
Woodline Partners LP (Filed by) CIK: 0001784547 (see all company filings)

IRS No.: 831749088 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Subject) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92875 | Film No.: 24620540
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)